ProShare Advisors
TSVT

ProShare Advisors’s 2seventy bio TSVT Stock Holding History

ProShare Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,906
Closed -$63.8K – 2188
2025
Q1 		$63.8K Sell
12,906
-3,300
-20% -$10.5K ﹤0.01% 1921
2024
Q4 		$47.6K Buy
+16,206
New +$66.5K ﹤0.01% 2182

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ProShare Advisors's TSVT Position: Q2 2025 in Review

ProShare Advisors sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 12,906 shares — an estimated $63.8K sold.

ProShare Advisors first reported a position in TSVT in Q4 2024 and held it in 2 quarters. The position peaked at $63.8K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • ProShare Advisors reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • ProShare Advisors sold 12,906 2seventy bio shares in Q2 2025, an estimated $63.8K.
  • ProShare Advisors first reported a position in 2seventy bio in Q4 2024 and held it in 2 quarters.
  • ProShare Advisors's 2seventy bio position peaked at $63.8K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.